-
L-Ornithine in Urea Cycle Research
2026-08-12
L-Ornithine enables controlled studies of OTC activity, nitrogen disposal, and liver–brain metabolic signaling without relying on poorly defined metabolic perturbations. This workflow-oriented guide connects reagent preparation with enzyme assays, astrocyte models, and troubleshooting strategies inspired by recent CNS toxicity research.
-
β-Amanitin for Reliable Transcription Assays
2026-08-11
Learn how β-Amanitin (SKU B8467) can support controlled RNA polymerase II inhibition, transcriptional regulation research, and interpretation of cell viability data. The article combines practical assay design, handling parameters, toxicology context, and evidence-based product selection.
-
Kanamycin Sulfate: Selection Workflows & Troubleshooting
2026-08-11
Kanamycin Sulfate supports reproducible bacterial selection, broth-dilution assays, and antibiotic resistance research without requiring ethanol or DMSO as a solvent. This practical guide connects a classic aminoglycoside susceptibility study with modern microbiology workflows, including assay design, controls, and troubleshooting.
-
LDN-193189 Workflows for BMP Research
2026-08-10
LDN-193189 enables selective ALK2/ALK3 interrogation in BMP-driven cell models, from corneal epithelial expansion to pathway-focused barrier assays. This guide translates the reference study’s six-component culture system into practical dosing, controls, troubleshooting, and follow-up experiments.
-
From Delivery Signal to Translation Proof
2026-08-09
A translational framework for using dual-fluorescence mRNA to distinguish cellular uptake from productive translation, informed by recent beta-cell-targeted lipid nanoparticle research and enabled by EZ Cap™ Cy5 EGFP mRNA (5-moUTP).
-
Indomethacin (A8449): Practical Lab Guide
2026-08-08
This guide helps researchers use Indomethacin as a controlled tool for cyclooxygenase inhibition, PPAR-related assays, inflammation research, lipid metabolism study, and membrane signaling modulation. It focuses on solvent handling, assay controls, and troubleshooting; it should not be used to infer clinical, in vivo, or universal cell-dosing conditions.
-
PEtOx Lipids as PEG Alternatives in mRNA LNPs
2026-08-07
The reference study evaluates poly(2-ethyl-2-oxazoline)-based lipids as substitutes for PEG-lipids in mRNA lipid nanoparticles, with polymer chain length treated as a key formulation variable. By combining physicochemical analysis, immune-response measurements, transfection studies, and super-resolution microscopy, the authors identify a PEtOx-LNP formulation that outperforms the commercial PEG-lipid comparator used in Comirnaty.
-
Targeting AR/ARv7 in TNBC: Insights from EPI-001 Functional
2026-08-07
This study investigates the prognostic role of androgen receptor (AR) and its splice variant ARv7 in triple-negative breast cancer (TNBC), revealing that ARv7 expression correlates with poorer survival and increased metastasis. The research demonstrates that inhibition of AR/ARv7 using EPI-001 and Enzalutamide in TNBC models reduces metastatic and EMT markers, offering mechanistic clarity for AR-targeted strategies.
-
PORCN Inhibition with LGK-974: A Breakthrough for Sclerosteo
2026-08-06
This study demonstrates that LGK-974, a potent PORCN inhibitor, can effectively attenuate the excessive bone growth seen in sclerosteosis by suppressing the Wnt/β-catenin signaling pathway. These findings highlight the first pharmacological approach to a disorder previously managed only by high-risk surgery, providing a foundation for future research in severe HBM pathologies.
-
HyperScript First-Strand cDNA Synthesis Kit: Extending RNA A
2026-08-06
Explore how the HyperScript First-Strand cDNA Synthesis Kit enables high-fidelity cDNA synthesis from challenging RNA templates, empowering researchers to dissect gene regulatory networks and low-abundance transcripts. This article uniquely bridges enzyme engineering and regulatory genomics for advanced molecular biology workflows.
-
NF 340: Selective P2Y11 Antagonist for GPCR Pathway Research
2026-08-05
NF 340 unlocks targeted inhibition of the P2Y11 receptor, enabling high-precision modulation of GPCR signaling in immunology and cancer research. Leverage its selectivity and robust workflow compatibility to dissect purinergic signaling in advanced experimental models.
-
Murine RNase Inhibitor: Optimizing RNA Stability in Molecula
2026-08-05
Murine RNase Inhibitor delivers robust, oxidation-resistant RNA protection, outperforming traditional inhibitors in sensitive applications like real-time RT-PCR and cDNA synthesis. Its proven specificity and stability unlock reliable results even under low-reducing conditions, making it indispensable for researchers seeking consistent RNA integrity.
-
Calnexin’s Role in CFTR Variant Expression and Corrector Eff
2026-08-04
Tedman et al. systematically mapped how the chaperone calnexin (CANX) modulates plasma membrane expression and drug response across hundreds of CFTR variants, revealing domain- and mutation-specific effects. Their findings provide a mechanistic basis for personalizing cystic fibrosis therapies and refining CFTR modulator screening.
-
8-Chloroadenosine: Precision Nucleoside Analog for RNA Studi
2026-08-04
8-Chloroadenosine stands out as a nucleoside analog for controlling RNA synthesis and dissecting transcriptional regulation workflows, particularly in cancer and lncRNA-focused research. This article delivers actionable protocol guidance, troubleshooting strategies, and key insights from the latest studies to empower advanced molecular biology experiments.
-
Metal-Free Carbon Nanozymes for Sensitive ALP Detection
2026-08-03
This study introduces a metal-free carbon dot nanozyme assay enabling highly sensitive and selective colorimetric detection of alkaline phosphatase (ALP) activity. The innovation addresses current limitations in ALP assays by eliminating metal ion interference and cytotoxicity, supporting reliable enzymatic measurements in complex biological samples.